Ioversol Market Report

Ioversol Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Oct 23, 2019
  • PAGES：144
  • REPORT CODE：GMM344718
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Ioversol market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.3% during the forecast period.

    This report presents the market size and development trends by detailing the Ioversol market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Ioversol market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Ioversol industry and will help you to build a panoramic view of the industrial development.

    Ioversol Market, By Type:

    • Ioversol 34% Injectable Solution (Optiray 160)

    • Ioversol 51% Injectable Solution (Optiray 240)

    • Ioversol 64% Injectable Solution (Optiray 300)

    • Ioversol 68% Injectable Solution (Optiray 320)

    • Ioversol 74% Injectable Solution (Optiray 350)

    Ioversol Market, By Application:

    • X-Ray

    • CT Scan

    • Brain Disorders,

    • Blood Vessel Disorders

    • Heart Disorders

    • Others

    Some of the leading players are as follows:

    • Guerbet

    • Ultraject

    • Jiangsu Hengrui Medicine Co

    • Liebel-Flarsheim Company LLC

    • Mallinckrodt Pharmaceuticals

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Ioversol Market: Technology Type Analysis

    • 4.1 Ioversol Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Ioversol Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Ioversol 34% Injectable Solution (Optiray 160)

      • 4.3.2 Ioversol 51% Injectable Solution (Optiray 240)

      • 4.3.3 Ioversol 64% Injectable Solution (Optiray 300)

      • 4.3.4 Ioversol 68% Injectable Solution (Optiray 320)

      • 4.3.5 Ioversol 74% Injectable Solution (Optiray 350)

    5 Ioversol Market: Product Analysis

    • 5.1 Ioversol Product Market Share Analysis, 2018 & 2026

    • 5.2 Ioversol Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Ioversol Market: Application Analysis

    • 6.1 Ioversol Application Market Share Analysis, 2018 & 2026

    • 6.2 Ioversol Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 X-Ray

      • 6.3.2 CT Scan

      • 6.3.3 Brain Disorders,

      • 6.3.4 Blood Vessel Disorders

      • 6.3.5 Heart Disorders

      • 6.3.6 Others

    7 Ioversol Market: Regional Analysis

    • 7.1 Ioversol Regional Market Share Analysis, 2018 & 2026

    • 7.2 Ioversol Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Guerbet

      • 9.1.1 Guerbet Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Ultraject

      • 9.2.1 Ultraject Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Jiangsu Hengrui Medicine Co

      • 9.3.1 Jiangsu Hengrui Medicine Co Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Liebel-Flarsheim Company LLC

      • 9.4.1 Liebel-Flarsheim Company LLC Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Mallinckrodt Pharmaceuticals

      • 9.5.1 Mallinckrodt Pharmaceuticals Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

     

    The List of Tables and Figures (Totals 69 Figures and 155 Tables)

    • Figure Ioversol 34% Injectable Solution (Optiray 160) Ioversol market, 2015 - 2026 (USD Million)

    • Figure Ioversol 51% Injectable Solution (Optiray 240) Ioversol market, 2015 - 2026 (USD Million)

    • Figure Ioversol 64% Injectable Solution (Optiray 300) Ioversol market, 2015 - 2026 (USD Million)

    • Figure Ioversol 68% Injectable Solution (Optiray 320) Ioversol market, 2015 - 2026 (USD Million)

    • Figure Ioversol 74% Injectable Solution (Optiray 350) Ioversol market, 2015 - 2026 (USD Million)

    • Figure X-Ray market, 2015 - 2026 (USD Million)

    • Figure CT Scan market, 2015 - 2026 (USD Million)

    • Figure Brain Disorders, market, 2015 - 2026 (USD Million)

    • Figure Blood Vessel Disorders market, 2015 - 2026 (USD Million)

    • Figure Heart Disorders market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Ioversol market, by country, 2015 - 2026 (USD Million)

    • Table North America Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table North America Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table North America Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table Canada Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table Canada Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Europe Ioversol market, by country, 2015 - 2026 (USD Million)

    • Table Europe Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table Europe Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table Europe Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table Germany Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table Germany Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table France Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table France Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table Italy Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table Italy Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table Spain Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table Spain Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Ioversol market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table China Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table China Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table Japan Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table Japan Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table India Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table India Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Ioversol market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table MEA Ioversol market, by country, 2015 - 2026 (USD Million)

    • Table MEA Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table MEA Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table MEA Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Ioversol market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Ioversol market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Ioversol market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Guerbet Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Ultraject Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Jiangsu Hengrui Medicine Co Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Liebel-Flarsheim Company LLC Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Mallinckrodt Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US